| Filing date | Description | Form | View |
|---|---|---|---|
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Initial filing by director officer or owner of more than ten percent. |
3 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML |
Data provided by Kaleidoscope.
2022
2021
Thursday, May 4, 2023, at 9:00 AM Pacific Time
The 2023 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) will be held on Thursday, May 4, 2023.
Stockholders of record of Nurix common stock as of the close of business on March 10, 2023, were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2022.
Additional information about the 2023 Annual Meeting of Stockholders may be found in our annual proxy statement filed with the SEC, which is available at the SEC Filings page found within the “Investors” section of our website.
'